These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23902655)

  • 21. The burden of neurological diseases in Europe: an analysis for the Global Burden of Disease Study 2017.
    Deuschl G; Beghi E; Fazekas F; Varga T; Christoforidi KA; Sipido E; Bassetti CL; Vos T; Feigin VL
    Lancet Public Health; 2020 Oct; 5(10):e551-e567. PubMed ID: 33007212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using disability-adjusted life years to set health-based targets: a novel use of an established burden of disease metric.
    Gibney K; Sinclair M; O'Toole J; Leder K
    J Public Health Policy; 2013 Aug; 34(3):439-46. PubMed ID: 23719293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Equity monitoring for social marketing: use of wealth quintiles and the concentration index for decision making in HIV prevention, family planning, and malaria programs.
    Chakraborty NM; Firestone R; Bellows N
    BMC Public Health; 2013; 13 Suppl 2(Suppl 2):S6. PubMed ID: 23902715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantifying the Disability from Congenital Anomalies Averted Through Pediatric Surgery: A Cross-Sectional Comparison of a Pediatric Surgical Unit in Kenya and Canada.
    Poenaru D; Pemberton J; Frankfurter C; Cameron BH
    World J Surg; 2015 Sep; 39(9):2198-206. PubMed ID: 26037026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Burden of COVID-19: Disability-Adjusted Life Years (DALYs) across 16 European countries.
    Gianino MM; Savatteri A; Politano G; Nurchis MC; Pascucci D; Damiani G
    Eur Rev Med Pharmacol Sci; 2021 Sep; 25(17):5529-5541. PubMed ID: 34533803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The global burden of disease attributable to high body mass index in 195 countries and territories, 1990-2017: An analysis of the Global Burden of Disease Study.
    Dai H; Alsalhe TA; Chalghaf N; Riccò M; Bragazzi NL; Wu J
    PLoS Med; 2020 Jul; 17(7):e1003198. PubMed ID: 32722671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modeling the patient and health system impacts of alternative xpert® MTB/RIF algorithms for the diagnosis of pulmonary tuberculosis in Addis Ababa, Ethiopia.
    Tesfaye A; Fiseha D; Assefa D; Klinkenberg E; Balanco S; Langley I
    BMC Infect Dis; 2017 May; 17(1):318. PubMed ID: 28464797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-Effectiveness of Exploratory Laparotomy in a Regional Referral Hospital in Eastern Uganda.
    Bellamkonda N; Motwani G; Wange AH; De Boer C; Kirya F; Juillard C; Marseille E; Ajiko MM; Dicker RA
    J Surg Res; 2020 Jan; 245():587-592. PubMed ID: 31499364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in malaria patterns in Brazil over 28 years (1990-2017): results from the Global Burden of Disease Study 2017.
    Bezerra JMT; Barbosa DS; Martins-Melo FR; Werneck GL; Braga ÉM; Tauil PL; Carneiro M
    Popul Health Metr; 2020 Sep; 18(Suppl 1):5. PubMed ID: 32993671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Disability-adjusted life years: an instrument for defining public health priorities?].
    Granados D; Lefranc A; Reiter R; Grémy I; Spira A
    Rev Epidemiol Sante Publique; 2005 Apr; 53(2):111-25. PubMed ID: 16012371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Setting priorities in health research using the model proposed by the World Health Organization: development of a quantitative methodology using tuberculosis in South Africa as a worked example.
    Hacking D; Cleary S
    Health Res Policy Syst; 2016 Feb; 14():10. PubMed ID: 26861120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa.
    Marseille E; Kahn JG; Mmiro F; Guay L; Musoke P; Fowler MG; Jackson JB
    Lancet; 1999 Sep; 354(9181):803-9. PubMed ID: 10485721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modeling the public health impact of malaria vaccines for developers and policymakers.
    Nunes JK; Cárdenas V; Loucq C; Maire N; Smith T; Shaffer C; Måseide K; Brooks A
    BMC Infect Dis; 2013 Jul; 13():295. PubMed ID: 23815273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disability-Adjusted Life Years Averted Versus Quality-Adjusted Life Years Gained: A Model Analysis for Breast Cancer Screening.
    Davidović M; Zielonke N; Lansdorp-Vogelaar I; Segnan N; de Koning HJ; Heijnsdijk EA
    Value Health; 2021 Mar; 24(3):353-360. PubMed ID: 33641769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Burden of non-communicable disease studies in Europe: a systematic review of data sources and methodological choices.
    Charalampous P; Gorasso V; Plass D; Pires SM; von der Lippe E; Mereke A; Idavain J; Kissimova-Skarbek K; Morgado JN; Ngwa CH; Noguer I; Padron-Monedero A; Santi-Cano MJ; Sarmiento R; Devleesschauwer B; Haagsma JA;
    Eur J Public Health; 2022 Apr; 32(2):289-296. PubMed ID: 35015851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Costs and health effects of breast cancer interventions in epidemiologically different regions of Africa, North America, and Asia.
    Groot MT; Baltussen R; Uyl-de Groot CA; Anderson BO; Hortobágyi GN
    Breast J; 2006; 12 Suppl 1():S81-90. PubMed ID: 16430401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost Per DALY Averted in a Surgical Unit of a Private Hospital in India.
    Chatterjee S; Laxminarayan R; Gosselin RA
    World J Surg; 2016 May; 40(5):1034-40. PubMed ID: 26675929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global burden of diseases, injuries, and risk factors for young people's health during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
    Mokdad AH; Forouzanfar MH; Daoud F; Mokdad AA; El Bcheraoui C; Moradi-Lakeh M; Kyu HH; Barber RM; Wagner J; Cercy K; Kravitz H; Coggeshall M; Chew A; O'Rourke KF; Steiner C; Tuffaha M; Charara R; Al-Ghamdi EA; Adi Y; Afifi RA; Alahmadi H; AlBuhairan F; Allen N; AlMazroa M; Al-Nehmi AA; AlRayess Z; Arora M; Azzopardi P; Barroso C; Basulaiman M; Bhutta ZA; Bonell C; Breinbauer C; Degenhardt L; Denno D; Fang J; Fatusi A; Feigl AB; Kakuma R; Karam N; Kennedy E; Khoja TA; Maalouf F; Obermeyer CM; Mattoo A; McGovern T; Memish ZA; Mensah GA; Patel V; Petroni S; Reavley N; Zertuche DR; Saeedi M; Santelli J; Sawyer SM; Ssewamala F; Taiwo K; Tantawy M; Viner RM; Waldfogel J; Zuñiga MP; Naghavi M; Wang H; Vos T; Lopez AD; Al Rabeeah AA; Patton GC; Murray CJ
    Lancet; 2016 Jun; 387(10036):2383-401. PubMed ID: 27174305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Economic Valuation of the Global Burden of Cleft Disease Averted by a Large Cleft Charity.
    Poenaru D; Lin D; Corlew S
    World J Surg; 2016 May; 40(5):1053-9. PubMed ID: 26669788
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.